vTv Therapeutics VTVT
NASDAQ VTVT
$30.57 -1.28 (-4.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Gains from Sales and Divestitures (2017 - 2019)

Updated

vTv Therapeutics (VTVT) posted Gains from Sales and Divestitures of -$6,000 for FY2025.

Analysis

vTv Therapeutics (VTVT) Gains from Sales and Divestitures (2017 - 2019) Analysis & Trends

Since FY2013, vTv Therapeutics has reported Gains from Sales and Divestitures for 8 years.

  • The FY2025 figure stands as the highest annual Gains from Sales and Divestitures since FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 vTv Therapeutics 379.35 Mn 379.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -24,000.00
Mar 31, 2018 12,000.00
Sep 30, 2017 16,000.00
Mar 31, 2017 -5,000.00
API Access

vTv Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VTVT&period=max&api_key=YOUR_API_KEY